Log in to save to my catalogue

Aptamer-antibody hybrid ELONA that uses hybridization chain reaction to detect a urinary biomarker E...

Aptamer-antibody hybrid ELONA that uses hybridization chain reaction to detect a urinary biomarker E...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb130f901cea445da36611c8a106fa85

Aptamer-antibody hybrid ELONA that uses hybridization chain reaction to detect a urinary biomarker EN2 for bladder and prostate cancer

About this item

Full title

Aptamer-antibody hybrid ELONA that uses hybridization chain reaction to detect a urinary biomarker EN2 for bladder and prostate cancer

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-07, Vol.12 (1), p.11523-11523, Article 11523

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

We report an EN2-specific (
K
d
 = 8.26 nM) aptamer, and a sensitive and specific enzyme-linked oligonucleotide assay (ELONA) for rapid and sensitive colorimetric detection of bladder and prostate cancer biomarker EN2 in urine. The assay relies on an aptamer-mediated hybridization chain reaction (HCR) to generate DNA nanostructures that bi...

Alternative Titles

Full title

Aptamer-antibody hybrid ELONA that uses hybridization chain reaction to detect a urinary biomarker EN2 for bladder and prostate cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cb130f901cea445da36611c8a106fa85

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb130f901cea445da36611c8a106fa85

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-15556-1

How to access this item